MARKET

PBE

PBE

Invesco Biotechnology & Genome ETF
NYSEARCA
67.22
+0.97
+1.46%
Closed 16:00 12/20 EST
OPEN
66.41
PREV CLOSE
66.25
HIGH
67.51
LOW
66.41
VOLUME
6.48K
TURNOVER
--
52 WEEK HIGH
72.84
52 WEEK LOW
59.31
TOTAL ASSET
271.89M
YTD YIELD
18.00%
1D
5D
1M
3M
1Y
5Y
1D
Operating Expenses Grow By Over $73B For U.S. Investment-Grade Companies In Q3
Seeking Alpha · 1d ago
Weekly Report: what happened at PBE last week (1209-1213)?
Weekly Report · 5d ago
Navigating The Health Care Industry In Trump's Second Term
Seeking Alpha · 12/12 08:40
2025 Annual Global Market Outlook: The Mechazilla Moment
Seeking Alpha · 12/11 09:00
Global X 2025 Outlook
Seeking Alpha · 12/10 08:40
Trump Presidency Poised To Shake Up The Healthcare Sector
Seeking Alpha · 12/09 17:30
Weekly Report: what happened at PBE last week (1202-1206)?
Weekly Report · 12/09 09:51
Capitalizing On The Inverse Stock-Bond Relationship With Multi-Asset Portfolios
Seeking Alpha · 12/07 10:15
More
Profile
Fund Name
Invesco Biotechnology & Genome ETF
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco
Custodian
The Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi